References
- Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252–263.
- Lodish HF, Zhou B, Liu G, et al. Micromanagement of the immune system by microRNAs. Nat Rev Immunol. 2008;8:120–130.
- Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol. 2014;15:565–576.
- Grimson A, Srivastava M, Fahey B, et al. Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals. Nature. 2008;455:1193–1197.
- Pfeffer S, Zavolan M, Grasser FA, et al. Identification of virus-encoded microRNAs. Science. 2004;304:734–736.
- Berezikov E. Evolution of microRNA diversity and regulation in animals. Nat Rev Genet. 2011;12:846–860.
- Kincaid RP, Sullivan CS. Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog. 2012;8:e1003018.
- Voinnet O. Origin, biogenesis, and activity of plant microRNAs. Cell. 2009;136:669–687.
- Bartel DP. Metazoan MicroRNAs. Cell. 2018;173:20–51.
- Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866.
- Rottiers V, Naar AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239–250.
- Rao P, Benito E, Fischer A. MicroRNAs as biomarkers for CNS disease. Front Mol Neurosci. 2013;6:39.
- Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861–874.
- Wahlquist C, Jeong D, Rojas-Munoz A, et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature. 2014;508:531–535.
- Lennox KA, Behlke MA. Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther. 2011;18:1111–1120.
- Hutvagner G, Simard MJ, Mello CC, et al. Sequence-specific inhibition of small RNA function. PLoS Biology. 2004;2:E98.
- Meister G, Landthaler M, Dorsett Y, et al. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. Rna. 2004;10:544–550.
- Elmen J, Lindow M, Schutz S, et al. LNA-mediated microRNA silencing in non-human primates. Nature. 2008;452:896–899.
- Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature. 2005;438:685–689.
- Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat.Methods. 2007;4:721–726.
- Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. Rna. 2010;16:2043–2050.
- Brown BD, Gentner B, Cantore A, et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol. 2007;25:1457–1467.
- Haraguchi T, Ozaki Y, Iba H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res.. 2009;37:e43.
- Hollensen AK, Thomsen R, Bak RO, et al. Improved microRNA suppression by WPRE-linked tough decoy microRNA sponges. Rna. 2017;23:1247–1258.
- Bak RO, Hollensen AK, Primo MN, et al. Potent microRNA suppression by RNA Pol II-transcribed ‘Tough Decoy’ inhibitors. Rna. 2013;19:280–293.
- Haraguchi T, Nakano H, Tagawa T, et al. A potent 2ʹ-O-methylated RNA-based microRNA inhibitor with unique secondary structures. Nucleic Acids Res. 2012;40:e58.
- Xie J, Ameres SL, Friedline R, et al. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat.Methods. 2012;9:403–409.
- Jeong D, Yoo J, Lee P, et al. miR-25 tough decoy enhances cardiac function in heart failure. Mol Therapy: Journal Am Soc Gene Ther. 2018;26:718–729.
- Kluiver J, Gibcus JH, Hettinga C, et al. Rapid generation of microRNA sponges for microRNA inhibition. PLoS One. 2012;7:e29275.
- Dhanasekaran R, Gabay-Ryan M, Baylot V, et al. Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC). Oncotarget. 2018;9:5517–5528.
- Marquitz AR, Mathur A, Nam CS, et al. The epstein-barr virus BART microRNAs target the pro-apoptotic protein Bim. Virology. 2011;412:392–400.
- Kang D, Skalsky RL, Cullen BR. EBV BART MicroRNAs target multiple pro-apoptotic cellular genes to promote epithelial cell survival. PLoS Pathog. 2015;11:e1004979.
- Bernhardt K, Haar J, Tsai MH, et al. A viral microRNA cluster regulates the expression of PTEN, p27 and of a bcl-2 Homolog. PLoS Pathog. 2016;12:e1005405.
- Choy EY, Siu KL, Kok KH, et al. An epstein-barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med. 2008;205:2551–2560.
- Feederle R, Linnstaedt SD, Bannert H, et al. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog. 2011;7:e1001294.
- Feederle R, Haar J, Bernhardt K, et al. The members of an epstein-barr virus microRNA cluster cooperate to transform B lymphocytes. J Virol. 2011;85:9801–9810.
- Xia T, O’Hara A, Araujo I, et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008;68:1436–1442.
- Nachmani D, Stern-Ginossar N, Sarid R, et al. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe. 2009;5:376–385.
- Haneklaus M, Gerlic M, Kurowska-Stolarska M, et al. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1beta production. J Immunol. 2012;189:3795–3799.
- Hooykaas MJG, van Gent M, Soppe JA, et al. EBV MicroRNA BART16 Suppresses Type I IFN Signaling. J Immunol. 2017;198:4062–4073.
- Tagawa T, Albanese M, Bouvet M, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065–2080.
- Albanese M, Tagawa T, Bouvet M, et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2016;113:E6467–E6475.
- Hooykaas MJ, Kruse E, Wiertz EJ, et al. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines. BMC Genomics. 2016;17:644.
- Lebbink RJ, Lowe M, Chan T, et al. Polymerase II promoter strength determines efficacy of microRNA adapted shRNAs. PLoS One. 2011;6:e26213.
- Lorenz R, Bernhart SH, Siederdissen HZ, et al. ViennaRNA Package 2.0. Algorithms for Molecular Biology: AMB. 2011;6:26.
- Bernhart SH, Muckstein U, Hofacker IL. RNA Accessibility in cubic time. Algorithms for Molecular Biology: AMB. 2011;6:3.
- Longnecker RM, Kieff E, Cohen JI. Epstein-Barr Virus. In: Knipe DM, Howley PM, editors. Fields Virology. 6th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2013. p. 1898–1959.
- Kertesz M, Iovino N, Unnerstall U, et al. The role of site accessibility in microRNA target recognition. Nat Genet. 2007;39:1278–1284.
- Tafer H, Ameres SL, Obernosterer G, et al. The impact of target site accessibility on the design of effective siRNAs. Nat Biotechnol. 2008;26:578–583.
- Mockenhaupt S, Grosse S, Rupp D, et al. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys. Proc Natl Acad Sci U S A. 2015;112:E4007–4016.